Association Between Immune-Mediated Adverse Events and Efficacy in Metastatic Non-Small-cell Lung Cancer Patients Treated with Durvalumab and Tremelimumab
Cancer Research（2021）
Key words
Immune-related Adverse Events
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined